Chimeric Antigen Receptor T Cell Stocks List

Symbol	Grade	Name	% Change
JANX	A	Janux Therapeutics, Inc.	0.74
GDTC	B	CytoMed Therapeutics Limited	-4.36
TSVT	D	2seventy bio, Inc.	1.38
CARM	D	Carisma Therapeutics, Inc.	2.72
CRBU	D	Caribou Biosciences, Inc.	12.76
PSTX	D	Poseida Therapeutics, Inc.	4.22
NTLA	F	Intellia Therapeutics, Inc.	4.15
ACET	F	Adicet Bio, Inc.	-2.34
SNTI	F	Senti Biosciences, Inc.	0.46
NKTX	F	Nkarta, Inc.	3.57

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
CNCR	F	Loncar Cancer Immunotherapy ETF	5.4
GNOM	F	Global X Genomics & Biotechnology ETF	3.84
ARKG	D	ARK Genomic Revolution Multi-Sector ETF	3.81
CANC	C	Tema Oncology ETF	3.47
ARKK	B	ARK Innovation ETF	2.25

Compare ETFs

Date	Stock	Title
Nov 1	JANX	Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors
Oct 31	NKTX	Nkarta (NKTX) Stock: Looking For Upside
Oct 31	NTLA	Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024
Oct 31	NTLA	Intellia Therapeutics (NTLA): Promising Gene Editing Stock with CRISPR-Cas9 Therapies
Oct 31	CRBU	Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock?
Oct 31	NKTX	Nkarta: Catalysts Ahead, But Competition In Cell Therapy Too (Rating Downgrade)
Oct 30	CARM	Carisma Therapeutics Announces Changes to its Board of Directors
Oct 30	NTLA	Reasons For Intellia Therapeutics Stock Plunge Are Flimsy, But Don't Buck Mr. Market
Oct 29	NTLA	Looking Into Intellia Therapeutics's Recent Short Interest
Oct 26	NTLA	Intellia Therapeutics Advances with Promising Phase 2 Results

Chimeric Antigen Receptor T Cell: Chimeric Antigen Receptor T Cell (CAR-T) is a type of immunotherapy that uses a patient’s own T cells to fight cancer. The T cells are genetically modified to express a special receptor, called a chimeric antigen receptor (CAR), which is designed to recognize and bind to a specific protein found on the surface of cancer cells. Once the CAR-T cells bind to the cancer cells, they can kill them. CAR-T therapy has been used to treat certain types of blood cancers, such as leukemia and lymphoma, and is being studied for other types of cancer.